Stereotaxic Depth Electrode Implantation | CMS Coverage Update

Summary: The Centers for Medicare & Medicaid Services modified its coverage policy for stereotaxic depth electrode implantation, effective May 15, 2026. Here's what billing teams need to know before that date.

CMS stereotaxic depth electrode implantation coverage policy changes don't come around often, but when they do, the financial exposure is real. This is a high-cost surgical procedure typically billed in neurology and neurosurgery settings, and any shift in CMS medical necessity criteria or prior authorization requirements can flip a paid claim into a denial fast. The policy does not list specific CPT or HCPCS codes in the available documentation — we'll address that directly in the code section below — but the modification itself signals that your billing team should audit current workflows before May 15, 2026.

Quick-Reference Table

CMS Stereotaxic Depth Electrode Implantation Coverage Criteria and Medical Necessity Requirements 2026

The CMS coverage policy for stereotaxic depth electrode implantation governs when Medicare will pay for the surgical placement of depth electrodes into brain tissue. This procedure is almost exclusively performed in the epilepsy monitoring unit setting. It's used to localize seizure foci in patients being evaluated for surgical resection — and it's not cheap. When CMS modifies this coverage policy, every neurosurgery billing team that touches Medicare should pay attention.

The underlying medical necessity standard for this procedure has historically centered on a few hard criteria. The patient must have medically refractory epilepsy. Non-invasive workup must have been exhausted or must have failed to localize the seizure focus adequately. And the procedure must be performed as part of a structured surgical epilepsy evaluation — not as a standalone diagnostic exercise.

Because the available policy documentation for this modification does not include the full updated criteria text, your billing team cannot rely on this post alone to confirm the exact medical necessity language as of May 15, 2026. Pull the current policy from the CMS website or through your Medicare Administrative Contractor directly. If you're not sure how your patient mix maps to the updated criteria, loop in your compliance officer before the effective date.

The prior authorization question is a real one here. CMS does not traditionally require prior authorization for most surgical procedures under fee-for-service Medicare. But Medicare Advantage plans — which use CMS coverage policy as a floor, not a ceiling — often impose their own prior authorization requirements on top of it. If your facility treats a significant Medicare Advantage population, check each plan's individual requirements for stereotaxic depth electrode procedures. Don't assume CMS fee-for-service rules apply to MA plans.

Reimbursement for this procedure is not trivial. Stereotaxic depth electrode implantation carries significant physician and facility work. Any tightening of medical necessity criteria directly translates to claim denial risk for cases that don't meet the updated standard.

CMS Stereotaxic Depth Electrode Implantation Exclusions and Non-Covered Indications

The policy documentation available for this modification does not enumerate specific non-covered indications or experimental designations. That said, CMS has historically drawn a clear line between covered and non-covered use cases for intracranial electrode procedures.

Coverage does not extend to diagnostic use outside of a structured surgical epilepsy evaluation. If a physician orders stereotaxic depth electrode placement for a non-epilepsy indication — or as a first-line diagnostic step without prior non-invasive evaluation — expect a denial. CMS considers that outside the established medical necessity framework.

Research use is also excluded from reimbursement under the standard coverage policy. If depth electrode placement is part of a clinical trial or investigational protocol, the billing pathway changes. That falls under the Clinical Trial Policy rules, not the standard surgical coverage determination. Your billing team needs to flag those cases separately.

Coverage Indications at a Glance

Because the policy documentation does not provide the updated full-text criteria for this modification, the table below reflects the established CMS framework for this procedure type. Verify each row against the May 15, 2026 policy text before using it for claim-level decisions.

CMS Stereotaxic Depth Electrode Implantation Billing Guidelines and Action Items 2026

Here's what your billing team should do before May 15, 2026.

CPT, HCPCS, and ICD-10 Codes for Stereotaxic Depth Electrode Implantation Under This Policy

Important Note on Codes

The policy documentation provided for this modification does not list specific CPT, HCPCS, or ICD-10 codes. This is not uncommon for CMS-level policy modifications — the procedure coverage determination often references the procedure conceptually, and code mapping falls to the physician and coder based on the CPT codebook and AMA guidance.

Your coding team should identify the applicable procedure codes for stereotaxic depth electrode implantation from the current CPT codebook. Look in the neurosurgery section, under intracranial procedures involving electrode placement. There are specific codes for stereotaxic procedures that your team should already be using — verify that those codes align with what this modified coverage policy covers.

For ICD-10-CM, your diagnosis coding should reflect the underlying condition driving the procedure — typically drug-resistant epilepsy. Work with your neurology team to confirm the appropriate diagnosis codes are captured at the encounter level before claim submission.

Do not guess at codes. If your coding team doesn't have a clear answer on which CPT codes apply, escalate to a certified neurosurgery coding specialist before May 15, 2026.